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There occurred two errors in the above manuscript (Pharm Res. 2015 Dec 30 \[Epub ahead of print\]). The correct information is as follows:The differential equations in Appendix 2 should read:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \begin{array}{l}\begin{array}{l}\mathrm{d}\left({\mathrm{A}}_{\mathrm{bv}}\right)/\mathrm{d}\mathrm{t}=\left({\mathrm{CL}}_{\mathrm{bv}}/{\mathrm{V}}_{\mathrm{plasma}}\right)\ast {\mathrm{A}}_{\mathrm{plasma}}-\left({\mathrm{CL}}_{\mathrm{bv}}/{\mathrm{V}}_{\mathrm{bv}}\right)\ast {\mathrm{A}}_{\mathrm{bv}}-\left({\mathrm{CL}}_{\mathrm{bev}}/{\mathrm{V}}_{\mathrm{bv}}\right)\ast {\mathrm{fu}}_{\mathrm{plasma}}\ast {\mathrm{A}}_{\mathrm{bv}}\hfill \\ {}+\left({\mathrm{CL}}_{\mathrm{bev}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}+\left({\mathrm{CL}}_{\mathrm{eff}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}\hfill \end{array}\hfill \\ {}\begin{array}{l}\mathrm{d}\left({\mathrm{A}}_{\mathrm{bev}}\right)/\mathrm{d}\mathrm{t}=\left({\mathrm{CL}}_{\mathrm{bev}}/{\mathrm{V}}_{\mathrm{bv}}\right)\ast {\mathrm{fu}}_{\mathrm{plasma}}\ast {\mathrm{A}}_{\mathrm{bv}}-\left({\mathrm{CL}}_{\mathrm{bev}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}-\left({\mathrm{CL}}_{\mathrm{eff}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}\hfill \\ {}-\left({\mathrm{CL}}_{\mathrm{st}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}+\left({\mathrm{CL}}_{\mathrm{st}}/{\mathrm{V}}_{\mathrm{st}\mathrm{f}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{f}}\hfill \end{array}\hfill \\ {}\begin{array}{l}\mathrm{d}\left({\mathrm{A}}_{\mathrm{st}\mathrm{f}}\right)/\mathrm{d}\mathrm{t}=\left({\mathrm{CL}}_{\mathrm{st}}/{\mathrm{V}}_{\mathrm{bev}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{bev}}-\left({\mathrm{CL}}_{\mathrm{st}}/{\mathrm{V}}_{\mathrm{st}\mathrm{f}}\right)\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{f}}-\mathrm{k}\mathrm{o}\mathrm{n}\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{f}}\ast \left({\mathrm{B}}_{\max }-\mathrm{C}\mathrm{B}\right)\hfill \\ {}+\mathrm{koff}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{b}}\hfill \end{array}\hfill \\ {}\mathrm{d}\left({\mathrm{A}}_{\mathrm{st}\mathrm{b}}\right)/\mathrm{d}\mathrm{t}=\mathrm{k}\mathrm{o}\mathrm{n}\ast {\mathrm{fu}}_{\mathrm{brain}}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{f}}\ast \left({\mathrm{B}}_{\max }-\mathrm{C}\mathrm{B}\right)-\mathrm{ko}\mathrm{f}\mathrm{f}\ast {\mathrm{A}}_{\mathrm{st}\mathrm{b}}\hfill \end{array} $$\end{document}$$Table [III](#Tab1){ref-type="table"} should read:Table III*In vitro*, *in vivo* and *ex vivo* values estimates used in the human D~2~RO predictive model.ClozapineHaloperidolOlanzapinePaliperidoneQuetiapineRisperidoneFraction unbound in brain0.011 ^a^0.023 ^b^0.034 ^a^0.0755 ^c^0.025 ^a^0.0699 ^c^Fraction unbound in plasma0.0300 ^d^0.0800 ^e^0.0700 ^m^0.226 ^f^0.170 ^e^0.100 ^f^Approach A: Human D~2~RO predictions based on *in vitro* informationPapp × 10^−6^ (cm/s)28.3 ^a^28.6 ^a^15.7 ^a^16.8 ^g^33.0 ^a^19.8 ^g^CL~bev~ (L/h) derived from Papp20.420.611.37.8023.812.96Efflux ratio------2.10 ^g^--1.20 ^g^CL~eff~ (L/h) based on ER------8.58--2.59*In vitro* Ki (nM)82.0 ^h^0.700 ^h^5.10 ^i^2.075 ^e^155 ^h^2.175 ^e^k~off~ (h^−1^)83.16 ^h^1.02 ^h^2.34 ^h^1.56 ^j,n^180.78 ^h^1.56 ^j^Approach B: Human D~2~RO predictions based on *in vivo* informationPapp~calc~ × 10^−6^ (cm/s)----100493 ^n^--493CL~bev~ (L/h) based on Papp~calc~----72.2355 ^n^--355CL~eff~ (L/h) scaled from rat----NA11594--2486k~off~ (h^−1^)----3.04 ^k^0.671 ^l,n^--0.671 ^l^Approach C: Human D~2~RO predictions integrating *in vitro* and *in vivo* informationCorrected *In vivo* Kd (nM)----4.380.352--0.395*NA* Not applicable^a^Reference (32); ^b^ Reference (33); ^c^ Reference (34); ^d^ Reference (35); ^e^ In-house values; ^f^ Reference (36); ^g^ Reference (37);^h^Reference (38); ^i^ Reference (39); ^j^ Reference (5); ^k^ Reference (7); ^l^ Reference (8); ^m^ Reference (40); ^n^Assumed to be equal to risperidone

The online version of the original article can be found at <http://dx.doi.org/10.1007/s11095-015-1846-4>.
